Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors

OBJECTIVE: Automated insulin delivery is the new standard for type 1 diabetes, but exercise-related hypoglycemia remains a challenge. Our aim was to determine whether a dual-hormone closed-loop system using wearable sensors to detect exercise and adjust dosing to reduce exercise-related hypoglycemia...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Care
Autori principali: Castle, Jessica R., El Youssef, Joseph, Wilson, Leah M., Reddy, Ravi, Resalat, Navid, Branigan, Deborah, Ramsey, Katrina, Leitschuh, Joseph, Rajhbeharrysingh, Uma, Senf, Brian, Sugerman, Samuel M., Gabo, Virginia, Jacobs, Peter G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2018
Soggetti:
Emerging Therapies: Drugs and Regimens
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014543/
https://ncbi.nlm.nih.gov/pubmed/29752345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-0228
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi